Stock Events

Acadia Pharmaceuticals (ACAD) Q1 2017 Earnings

28FebConfirmed
Q2 2016
Q3 2016
Q4 2016
Q1 2017
-0.66
-0.58
-0.51
-0.43

Details

Expected EPS
-0.66
Actual EPS
-0.65
Surprise EPS
0.01
Surprise Percent
+1.52%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.65 per share for Q1 2017.

0 Comments

Share your thoughts